Summary
The rationale and history of the development of physiologically based pharmacokinetic models are briefly reviewed in this paper. The methods of model construction and the previous application of this type of model to anticancer drugs are discussed.
Future research should be focused on the following areas: (1) interspecies scaling, (2) the effects of disease states on the pharmacokinetics of anticancer drugs, and (3) the applications of pharmocokinetics to the studies of growth behavior of cancer cells. The ultimate goal will be to utilize this basic information to design an optimal dosage regimen and treatment schedule for the safe and effective cancer chemotherapy of each individual patient.
Similar content being viewed by others
References
Anderson, M. W., Eling, T. E., Lutz, R. J., Dedrick, R. L., Matthews, H. B.: The construction of a pharmacokinetic model for the disposition of polychlorinated biphenyls in the rat. Clin. Pharmacol. Ther. 22, 765–773 (1977)
Ashman, M. N., Blesser, W. B., Epstein, R. M.: A nonlinear model for the uptake and distribution of halothane in man. Anesthesiology 33, 419–429 (1970)
Benowitz, N., Forsyth, R. P., Melmon, K. L., Rowland, M.: Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model. Clin. Pharmacol. Ther. 16, 87–98 (1974a)
Benowitz, N., Forsyth, R. P., Melmon, K. L., Rowland, M.: Lidocaine disposition kinetics in monkey and man. II. Effects of hemorrhage and sympathomimetic drug administration. Clin. Pharmacol. Ther. 16, 99–109 (1974b)
Bischoff, K. B.: Applications of a mathematical model for drug distribution in mammals. In: Chemical engineering in medicine and biology. Hershey, D. (ed.). New York: Plenum Press 1967
Bischoff, K. B.: Some fundamental considerations of the applications of pharmacokinetics to cancer chemotherapy. Cancer Chemother. Rep. [1] 59, 777–793 (1975)
Bischoff, K. B., Brown, R. G.: Drug distribution in mammals. Chem. Eng. Prog. Symp. Ser. 62, (66), 32–45 (1966)
Bischoff, K. B., Dedrick, R. L.: Thiopental pharmacokinetics. J. Pharm. Sci. 57, 1346–1351 (1968)
Bischoff, K. B., Dedrick, R. L., Zaharko, D. S.: Preliminary model for methotrexate pharmacokinetics. J. Pharm. Sci. 59, 149–154 (1970)
Bischoff, K. B., Dedrick, R. L., Zaharko, D. S., Longstreth, J. A.: Methotrexate pharmacokinetics. J. Pharm. Sci. 60, 1128–1133 (1971)
Bischoff, K. B., Himmelstein, K. J., Dedrick, R. L., Zaharko, D. S.: Pharmacokinetics and cell population growth models in cancer chemotherapy. In: Chemical engineering in medicine advanced chemistry series, Vol. 118, pp. 47–64 Washington, DC: A.S.C. 1973
Boxenbaum, H. G., Riegelman, S., Elashoff, R. M.: Statistical estimations in pharmacokinetics. J. Pharmacokinet. Biopharm. 2, 123–148 (1974)
Chan, K. K., Cohen, J. L., Gross, J. F., Himmelstein, K. J., Bateman, J. R., Tsu-Lee, Y., Marlis, A. S.: Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model. Cancer Treat. Rep. 62, 1161–1171 (1978)
Chen, C. N., Andrale, J. D.: Pharmacokinetic model for simultaneous determination of drug levels in organs and tissues. J. Pharm. Sci. 65, 717–724 (1976)
Chen, H.-S. G., Gross, J. F.: Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models. J. Pharmacokinet. Biopharm. 7, 117–125 (1979)
Chen, H.-S. G., Gross, J. F.: The role of physiologically based pharmacokinetics in the optimal design of cytotoxic drug regimes. 71st Annual Meeting, Am. Inst. Chem. Eng., Miami, Florida, November 15, 1978
Chen, C. N., Coleman, D. L., Andrade, J. D., Temple, A. R.: Pharmacokinetic model for salicylate in cerebrospinal fluid, blood, organs, and tissues. J. Phar. Sci. 67, 38–45 (1978)
Dedrick, R. L.: Animal scale-up. J. Pharmacokin. Biopharm. 1, 435–461 (1973)
Dedrick, R. L., Bischoff, K. B.: Pharmacokinetics in applications of the artificial kidney. Chem. Eng. Prog. Symp. Ser. 64 (84), 32–44 (1968)
Dedrick, R. L., Forrester, D. D., Ho, D. H. W.: In vitro-in vivo correlation of drug metabolism — deamination of 1-β-D-arabinofuranosylcytosine. Biochem. Pharmacol. 21, 1–16 (1972)
Dedrick, R. L., Forrester, D. D., Cannon, J. N., El Dareer, S. M., Mellett, L. B.: Pharmacokinetics of 1-β-D-arabinofuranosylcytosine (Ara-C) deamination in several species. Biochem. Pharmacol. 22, 2405–2417 (1973a)
Dedrick, R. L., Zaharko, D. S., Lutz, R. J.: Transport and binding of methotrexate in vivo. J. Pharm. Sci. 62, 882–890 (1973b)
Dedrick, R. L., Zaharko, D. S., Bender, R. A., Bleyer, W. A., Lutz R. J.: Pharmacokinetic consideration of resistance to anticancer drugs. Cancer Chemother. Rep. [1] 59, 759–803 (1975)
Dedrick, R. L., Myers, C. E., Bungay, P. M., DeVita, V. T., Jr.: Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat. Rep. 62, 1–11 (1978)
Gabelnick, H. L., Dedrick, R. L., Bourke, R. S.: In vivo mass transfer of chloride during exchange hemodialysis. J. Appl. Physiol. 28, 636–641 (1970)
Gibaldi, M., Perrier, D.: Pharmacokinetics. New York: Marcel Dekker 1975
Gillis, P. P., DeAngelis, R. J., Wynn, R. L.: Nonlinear pharmacokinetic model of intravenous anesthesia. J. Pharm. Sci. 65, 1001–1006 (1976)
Greene, D. S., Quintiliani, R., Nightingale, C. H.: Physiological perfusion model for cephalosporin antibiotics. I: model selection based on blood drug concentrations. J. Pharm. Sci. 67, 191–196 (1978)
Harris, P. A., Gross, J. F.: Preliminary pharmacokinetic model for adriamycin (NSC-123127). Cancer Chemother. Rep. [1] 59, 819–825 (1975)
Harrison, L. E., Gibaldi, M.: Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat. J. Pharm. Sci. 66, 1138–1142 (1977a)
Harrison, L. I., Gibaldi, M.: Physiologically based pharmacokinetic model for digoxin disposition in dogs and its preliminary application to human. J. Pharm. Sci. 66, 1679–1683 (1977b)
Himmelstein, K. J., Bischoff, K. B.: Mathematical representation of cancer chemotherapy effects. J. Pharmacokinet. Biopharm. 1, 51–68 (1973a)
Himmelstein, K. J., Bischoff, K. B.: Models of Ara-C chemotherapy of L1210 leukemia in mice. J. Pharmacokinet. Biopharm. 1, 69–81 (1973b)
Himmelstein, K. J., Gross, J. F.: Mathematical model for cyclocytidine pharmacokinetics. J. Pharm. Sci. 66, 1441–1444 (1977)
Hoeschele, J. D., VanCamp, L.: Whole-body counting and the distribution of cis-195m-(Pt(NH3)2Cl2) in the major organs of Swiss white mice. In: Advances in antimicrobial and antineoplastic chemotherapy. Vol. 2, pp. 241–242. Baltimore, Md.: University Park Press 1972
LeRoy, A. F., Dedrick, R. L., Lutz, R. J., Litterest, C. L., Guarino, A. M.: Pharmacokinetic study of cis-dichlorodiammine-platinum (DDP) in the beagle dog — thermodynamic and kinetic behavior of DDP in biological milieux. Cancer Treat. Rep. (In press, 1979)
Lincoln, T. L., Morrison, P. F., Aroesty, J., Carter, G. M.: The computer simulation of leukemia therapy: combined pharmacokinetics, intracellular enzyme kinetics, and cell kinetics of treatment of L1210 leukemia by cytosine arabinoside. Cancer Treat. Rep. 60, 1723–1739 (1976)
Lutz, R. J., Dedrick, R. L., Straw, J. A., Hart, M. M., Klubes, P., Zaharko, D. S.: The kinetics of methotrexate distribution in spontaneous canine lymphosarcoma. J. Pharmacokinet. Biopharm. 3, 77–97 (1975)
Lutz, R. J., Dedrick, R. L., Matthews, H. B., Eling, T. E., Anderson, M. W.: A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat. Drug. Metab. Dispos. 5, 386–396 (1977a)
Lutz, R. L., Galbraith, W. M., Dedrick, R. L., Shrager, R., Mellett, L. B.: A model for the kinetics of distribution of actinomycin D in the beagle dog. J. Pharmacol. Exp. Ther. 200, 469–478 (1977b)
Montandon, B., Roberts, R. J., Fischer, L. J.: Computer simulation of sulfobromophthalein kinetics in the rat using flow-limited models with extrapolation to man. J. Pharmacokinet. Biopharm. 3, 277–290 (1975)
Morrison, P. F., Lincoln, T. L., Aroesty, J.: The disposition of Ara-C and its metabolites: a pharmacokinetic simulation. Cancer chemother. Rep. [1] 59, 861–876 (1975)
Munson, E. S., Eger, E. I., II, Bowers, D. L.: Effect of anesthetic-depressed ventilation and cardiac output on anesthetic uptake. Anesthesiology 38, 251–259 (1973)
Smith, N. T., Zwart, A., Beneken, J. E. W.: Interaction between the circulatory effects and the uptake and distribution of halothane. Anesthesiology 37, 47–58 (1972)
Tterlikkis, L., Ortega, E., Solomon, R., Day, J. L.: Pharmacokinetics of mercaptopurine. J. Pharm. Sci. 66, 1454–1457 (1977)
Tuey, D. B., Matthews, H. B.: Pharmacokinetics of 3,3′,5,5′-tetrachlorobiphenyl in the male rat. Drug Metab. Dispos. 5, 444–450 (1977)
Wagner, J. G.: Biopharmaceutics and relevant pharmacokinetics. Hamilton, Ill.: Drug Intelligence Publications 1971
Wagner, J. G.: Fundamentals of clinical pharmacokinetics. Hamilton, Ill.: Drug Intelligence Publications 1975
Zaharko, D. S., Dedrick, R. L., Bischoff, K. B., Longstreth, J. A., Oliverio, V. T.: Methotrexate tissue distribution: prediction by a mathematical model. J. Natl. Cancer Inst. 46, 775–784 (1971)
Zaharko, D. S., Dedrick, R. L., Oliverio, V. T.: Prediction of the distribution of methotrexate in the sting rays Dasyatidae sabina and sayi by use of a model developed in mice. Comp. Biochem. Physiol. [A] 42, 183–194 (1972)
Zaharko, D. S., Dedrick, R. L., Peale, A. L., Drake, J. C., Lutz, R. L.: Relative toxicity of methotrexate in several tissues of mice bearing Lewis lung carcinoma. J. Pharmacol. Exp. Ther. 189, 585–592 (1974)
Zwart, A., Smith, N. T., Beneken, E. W.: Multiple model approach to uptake and distribution of halothane: the use of an analog computer. Comput. Biomed. Res. 5, 228–238 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, HS.G., Gross, J.F. Physiologically based pharmacokinetic models for anticancer drugs. Cancer Chemother. Pharmacol. 2, 85–94 (1979). https://doi.org/10.1007/BF00254079
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00254079